Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus.
Suckling in the lactating rat (days 6-10 of lactation) was used to characterize the effects of intracerebral oxytocin (Oxt) antisense oligonucleotide treatment on the hypothalamo-neurohypophysial system. Vehicle, mixed bases, Oxt antisense, or vasopressin antisense oligonucleotides (2.5 micrograms/0.5 microliter each) were infused directly into the left and right supraoptic nucleus (SON), 4 h before a litter of 10 pups was allowed to suckle for 30 min. In the Oxt antisense group, there was a significant reduction in the number of milk ejection reflexes (to 34.6 +/- 4.88%, P < 0.001), as well as in the weight gain of the litter (to 18.8 +/- 6.98%, P < 0.03) compared with vehicle (100%)-, mixed base-, or vasopressin antisense-treated animals, which did not differ from each other. The time to onset of suckling, however, was unchanged. Compared with presuckling values, plasma Oxt was significantly increased in all four groups 30 min after onset of suckling (vehicle, to 325 +/- 117%; mixed bases, to 258 +/- 48.2%; vasopressin antisense, to 330 +/- 55.7%), but this increase was less pronounced in Oxt antisense-treated rats (to 157 +/- 20.5%; P < 0.05 vs. vasopressin antisense). In contrast to these changes in neuroendocrine functions during suckling, Oxt as well as vasopressin content and Oxt immunoreactivity in posterior pituitaries and the SON, respectively, did not differ among groups. Our data indicate rapid and specific effects of an Oxt antisense oligonucleotide infused into the SON on neuroendocrine, suckling-related parameters that are not due to depleted stores of Oxt in the hypothalamo-neurohypophysial system.
Neumann
I
I
Neuroscience Research Group, University of Calgary, Alberta, Canada.
Porter
D W
DW
Landgraf
R
R
Pittman
Q J
QJ
D000818:Animals; D016375:Antisense Elements (Genetics) / Q000235:genetics; D001483:Base Sequence; D005260:Female; D007150:Immunohistochemistry; D007774:Lactation / Q000187:drug effects* / Q000502:physiology; D008969:Molecular Sequence Data; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D010121:Oxytocin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D010904:Pituitary Gland, Posterior / Q000378:metabolism; D051381:Rats; D013495:Supraoptic Nucleus / Q000502:physiology*; D014667:Vasopressins / Q000097:blood / Q000378:metabolism
D016375:Antisense Elements (Genetics); D016376:Oligonucleotides, Antisense; D014667:Vasopressins; D010121:Oxytocin